A detailed history of Mackenzie Financial Corp transactions in Incyte Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 260,073 shares of INCY stock, worth $18.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
260,073
Previous 381,704 31.87%
Holding current value
$18.2 Million
Previous $23.1 Million 25.71%
% of portfolio
0.03%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $6.97 Million - $8.35 Million
-121,631 Reduced 31.87%
260,073 $17.2 Million
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $620,045 - $772,331
-12,115 Reduced 3.08%
381,704 $23.1 Million
Q1 2024

May 10, 2024

BUY
$56.55 - $66.59 $1.13 Million - $1.33 Million
20,030 Added 5.36%
393,819 $22.4 Million
Q4 2023

Jan 30, 2024

BUY
$52.16 - $64.19 $2.38 Million - $2.93 Million
45,578 Added 13.89%
373,789 $23.5 Million
Q3 2023

Oct 25, 2023

BUY
$57.77 - $65.93 $1.83 Million - $2.09 Million
31,750 Added 10.71%
328,211 $19 Million
Q2 2023

Aug 03, 2023

BUY
$60.95 - $75.51 $3.27 Million - $4.05 Million
53,641 Added 22.09%
296,461 $18.5 Million
Q1 2023

Apr 24, 2023

BUY
$70.23 - $86.01 $97,760 - $119,725
1,392 Added 0.58%
242,820 $17.5 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $3.8 Million - $4.76 Million
56,584 Added 30.61%
241,428 $19.4 Million
Q3 2022

Oct 07, 2022

BUY
$66.18 - $82.86 $1.78 Million - $2.23 Million
26,880 Added 17.02%
184,844 $12.3 Million
Q2 2022

Aug 10, 2022

BUY
$66.18 - $83.18 $2.61 Million - $3.29 Million
39,500 Added 33.34%
157,964 $12 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $4.42 Million - $5.33 Million
66,921 Added 129.84%
118,464 $9.41 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $686,098 - $802,759
10,832 Added 26.61%
51,543 $3.78 Million
Q3 2021

Nov 08, 2021

BUY
$68.67 - $84.02 $382,285 - $467,739
5,567 Added 15.84%
40,711 $2.8 Million
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $505,896 - $554,415
6,334 Added 21.99%
35,144 $2.96 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $97,533 - $128,941
-1,283 Reduced 4.26%
28,810 $2.34 Million
Q4 2020

Feb 10, 2021

BUY
$80.74 - $97.7 $611,766 - $740,272
7,577 Added 33.65%
30,093 $2.62 Million
Q3 2020

Nov 13, 2020

SELL
$85.07 - $109.69 $421,862 - $543,952
-4,959 Reduced 18.05%
22,516 $2.02 Million
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $707,603 - $1.04 Million
9,539 Added 53.18%
27,475 $0
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $262,576 - $357,291
-4,156 Reduced 18.81%
17,936 $0
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $1.61 Million - $2.11 Million
22,092 New
22,092 $1.93 Million
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $192,754 - $229,018
-2,647 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $3.43 Million - $4.14 Million
-46,678 Reduced 94.63%
2,647 $225,000
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $3.14 Million - $4.35 Million
49,325 New
49,325 $4.24 Million
Q2 2018

Aug 13, 2018

SELL
$60.85 - $83.98 $173,422 - $239,343
-2,850 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $236,721 - $287,793
2,850 New
2,850 $237,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.